BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$803M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$683M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$676M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$612M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$570M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.92B |
| 2 |
Meta Platforms (Facebook)
META
|
+$899M |
| 3 |
Amazon
AMZN
|
+$705M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$698M |
| 5 |
GE Vernova
GEV
|
+$545M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Financials | 7.92% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Healthcare | 6.49% |
| 5 | Industrials | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
CALL
Archer Daniels Midland
ADM
$38.7B
| $3.35M | ﹤0.01% |
461
-1,733
| -79% | -$117K |
|
2227
CALL
Nucor
NUE
$58.3B
| $3.35M | ﹤0.01% |
198
-162
| -45% | -$28.2K |
|
2228
Privia Health
PRVA
$3.04B
| $3.34M | ﹤0.01% |
162,576
+32,472
| +25% | +$732K |
|
|
KRAQU
2229
KRAKacquisition Corp Unit
KRAQU
| $3.34M | ﹤0.01% |
+333,700
| New | +$3.36M |
|
|
ENHA
2230
Enhanced Group Inc
ENHA
$341M
| $3.33M | ﹤0.01% |
327,714
+37,264
| +13% | +$377K |
|
2231
Iridium Communications
IRDM
$4.7B
| $3.33M | ﹤0.01% |
119,989
-64,160
| -35% | -$1.44M |
|
|
VHCP
2232
Vine Hill Capital Investment Corp II
VHCP
$307M
| $3.32M | ﹤0.01% |
+334,992
| New | +$3.32M |
|
2233
Medpace
MEDP
$16.3B
| $3.3M | ﹤0.01% |
6,871
-1,448
| -17% | -$741K |
|
|
ONT
2234
Onterris Inc
ONT
$731M
| $3.29M | ﹤0.01% |
150,373
+32,581
| +28% | +$782K |
|
|
AXIN
2235
Axiom Intelligence Acquisition Corp 1
AXIN
$280M
| $3.28M | ﹤0.01% |
323,504
+37,230
| +13% | +$377K |
|
2236
SLM Corp
SLM
$4.83B
| $3.27M | ﹤0.01% |
152,913
+44,990
| +42% | +$1.06M |
|
|
CRESY
2237
Cresud
CRESY
$806M
| $3.27M | ﹤0.01% |
257,313
+171,557
| +200% | +$2.09M |
|
2238
Invesco S&P 500 Pure Growth ETF
RPG
$1.9B
| $3.27M | ﹤0.01% |
70,000
-105,950
| -60% | -$5.15M |
|
2239
FNB Corp
FNB
$6.76B
| $3.26M | ﹤0.01% |
195,206
+102,848
| +111% | +$1.78M |
|
2240
PUT
Chubb
CB
$140B
| $3.26M | ﹤0.01% |
100
-157
| -61% | -$50.4K |
|
2241
Riley Exploration Permian
REPX
$728M
| $3.26M | ﹤0.01% |
89,377
+71,777
| +408% | +$2.14M |
|
2242
PUT
Ball Corp
BALL
$17.5B
| $3.25M | ﹤0.01% |
+550
| New | +$33.5K |
|
2243
Travere Therapeutics
TVTX
$5.17B
| $3.25M | ﹤0.01% |
109,382
-556,413
| -84% | -$16.6M |
|
2244
Monarch Casino & Resort
MCRI
$2.2B
| $3.25M | ﹤0.01% |
33,988
+4,944
| +17% | +$470K |
|
|
DEC
2245
Diversified Energy Company
DEC
$902M
| $3.24M | ﹤0.01% |
185,812
+171,650
| +1,212% | +$2.42M |
|
2246
Option Care Health
OPCH
$3.58B
| $3.23M | ﹤0.01% |
119,975
+51,917
| +76% | +$1.69M |
|
|
KTWO
2247
K2 Capital Acquisition Corp
KTWO
$200M
| $3.23M | ﹤0.01% |
+327,210
| New | +$3.23M |
|
2248
ADC Therapeutics
ADCT
$140M
| $3.23M | ﹤0.01% |
860,491
+29,588
| +4% | +$117K |
|
2249
Moelis & Co
MC
$4.85B
| $3.23M | ﹤0.01% |
56,583
+24,029
| +74% | +$1.56M |
|
|
DBCA
2250
D. Boral Acquisition I Corp
DBCA
$432M
| $3.21M | ﹤0.01% |
+325,980
| New | +$3.21M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Financial Markets held 6,247 positions worth $206B, down 6.7% from $221B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q1 2026 filing shows 521 new, 2,339 increased, 2,351 reduced and 443 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M. The largest sale was Apple, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q1 2026 buy was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M.
- BNP Paribas Financial Markets added most to Oracle in Q1 2026, an estimated $803M increase.
- BNP Paribas Financial Markets's biggest Q1 2026 reduction was Apple, cutting an estimated $1.92B.
- BNP Paribas Financial Markets fully exited Flutter Entertainment in Q1 2026, selling an estimated $332M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $206B portfolio in Q1 2026.
- BNP Paribas Financial Markets opened 521 new positions and closed 443 in Q1 2026.
- BNP Paribas Financial Markets's portfolio value fell 6.7% quarter-over-quarter to $206B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.